Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $8.04, but opened at $8.46. Oxford BioMedica shares last traded at $8.46, with a volume of 186 shares changing hands.
Oxford BioMedica Stock Up 5.2%
The company has a current ratio of 1.89, a quick ratio of 1.67 and a debt-to-equity ratio of 3.08. The firm’s 50 day moving average is $8.19 and its 200 day moving average is $6.38.
About Oxford BioMedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
See Also
- Five stocks we like better than Oxford BioMedica
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Microsoft Stock Faces An AI-Driven Physics Problem
- ETF Screener: Uses and Step-by-Step Guide
- Is It Time to Invest in Your Kid’s Favorite Gaming Platform?
- How is Compound Interest Calculated?
- 5 Stocks to Buy Before Santa Claus Comes to Town
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
